Its ability to reduce IL-2 signalling and promote IL-10 makes it theoretically attractive for ME/CFS, but risks like thrombosis and viral reactivation would warrant caution. Here, IL2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.